Cargando…
Modified-Release Hydrocortisone: Is It Time to Change Clinical Practice?
The appreciation of the unacceptable outcomes of patients with adrenal insufficiency has brought new developments in glucocorticoid replacement therapy. Efforts have moved beyond simple dose adjustments of the traditional immediate-release hydrocortisone to new formulations of hydrocortisone aimed a...
Autor principal: | Stewart, Paul M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532954/ https://www.ncbi.nlm.nih.gov/pubmed/31139761 http://dx.doi.org/10.1210/js.2019-00046 |
Ejemplares similares
-
Early Metabolic Benefits of Switching Hydrocortisone to Modified Release Hydrocortisone in Adult Adrenal Insufficiency
por: Bannon, Christopher A. M., et al.
Publicado: (2021) -
Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
por: Merke, Deborah P, et al.
Publicado: (2021) -
Chronotherapy based on modified-release hydrocortisone to restore the physiological cortisol diurnal rhythm
por: Whitaker, Martin J., et al.
Publicado: (2022) -
The use of prednisolone versus dual-release hydrocortisone in the treatment of hypoadrenalism
por: Choudhury, Sirazum, et al.
Publicado: (2021) -
Integrating functional ageing into daily clinical practice
por: Michel, Jean-Pierre, et al.
Publicado: (2019)